News & Media

Explore the latest news from our company and stay up-to-date with our upcoming events.

Key figures

  • 21.0

    billion euro net sales in 2023

  • 5.9

    billion euro EBITDA pre in 2023

  • 63000

    employees around the world

Latest News

View all news
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership

    Memorandum of Understanding signed to drive digital transformation through strategic projects across all three business sectors

    2024/09/16

  2. Press Releases

    Merck KGaA, Darmstadt, Germany Unveils New MAVENCLAD® Four-Year ...

    The company today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine) tablets in relapsing multiple sclerosis.

    2024/09/12

  3. Press Releases

    MilliporeSigma Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing

    MilliporeSigma launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs).

    2024/09/10

Stay up-to-date

You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe

  • Media Contacts

    for journalists, bloggers or multipliers.

    Get in touch!
  • Media downloads

    Browse and download high-quality images and video footage.
    Access gallery
  • Press Kits

    with all the facts and relevant background information on particularly important topics.

    Collected Topics
  • Strategy & Values

    We believe in science and technology as a force for good.

    Learn more
  • Stories

    Learn more about our company and the people behind it.

    Learn more
  • Sustainability

    We want to create long-term added value for society.

    Learn more
  • Our sites

    Learn where you can find us around the world.

    Learn more

Upcoming Events

View All Events